Differences in Survival Between Colon and Rectal Cancer from SEER Data

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Nov 23

PMID 24265711

Citations 77

Authors

Yen-Chien Lee

Yen-Lin Lee

Jen-Pin Chuang

Jenq-Chang Lee

Affiliations

Soon will be listed here.

Abstract

Background: Little is known about colorectal cancer or colon and rectal cancer. Are they the same disease or different diseases?

Objectives: The aim of this epidemiology study was to compare the features of colon and rectal cancer by using recent national cancer surveillance data.

Design And Setting: Data included colorectal cancer (1995-2008) from the Surveillance, Epidemiology, and End Results Program (SEER) database. Only adenocarcinoma was included for analysis.

Patients: A total of 372,130 patients with a median follow-up of 32 months were analyzed.

Main Outcome Measures: Mean survival of patients with the same stage of colon and rectal cancer was evaluated.

Results: Around 35% of patients had stage information. Among them, colon cancer patients had better survival than those with rectal cancer, by a margin of 4 months in stage IIB. In stage IIIC and stage IV, rectal cancer patients had better survival than colon cancer patients, by about 3 months. Stage IIB colorectal cancer patients had a poorer prognosis than those with stage IIIA and IIIB colorectal cancer. After adjustment of age, sex and race, colon cancer patients had better survival than rectal cancer of stage IIB, but in stage IIIC and IV, rectal cancer patients had better survival than colon cancer.

Limitations: The study is limited by its retrospective nature.

Conclusion: This was a population-based study. The prognosis of rectal cancer was not worse than that of colon cancer. Local advanced colorectal cancer had a poorer prognosis than local regional lymph node metastasis. Stage IIB might require more aggressive chemotherapy, and no less than that for stage III.

Citing Articles

Adjuvant Chemotherapy for High-Risk Stage II Colon Cancer: A Population-Based Study.

Butare A, Sutton T, Kantzler E, Kennedy K, Tumin D, Honaker M J Gastrointest Cancer. 2025; 56(1):63.

PMID: 39945928 PMC: 11825529. DOI: 10.1007/s12029-025-01186-z.

Optimizing colorectal cancer segmentation with MobileViT-UNet and multi-criteria decision analysis.

Barua B, Chyrmang G, Bora K, Saikia M PeerJ Comput Sci. 2025; 10:e2633.

PMID: 39896394 PMC: 11784762. DOI: 10.7717/peerj-cs.2633.

Chinese herbal medicine (JianPi-BuShen) and completion rate of adjuvant chemotherapy for patients with stage II and III colon cancer: A randomized clinical trial.

Sun L, Xu Y, Chen N, Zhang C, Wu A, Wang H Eur J Cancer. 2024; 213:115109.

PMID: 39509846 PMC: 11622473. DOI: 10.1016/j.ejca.2024.115109.

Racial comparisons in treatment of rectal adenocarcinoma and survival in the military health system.

Eaglehouse Y, Darmon S, Gage M, Shriver C, Zhu K JNCI Cancer Spectr. 2024; 8(5).

PMID: 39208282 PMC: 11413531. DOI: 10.1093/jncics/pkae074.

Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data.

Brenner B, Shulman K, Hubert A, Man S, Geva R, Ben-Aharon I ESMO Open. 2024; 9(8):103648.

PMID: 39137478 PMC: 11369429. DOI: 10.1016/j.esmoop.2024.103648.

References

Harnack L, Jacobs Jr D, Nicodemus K, Lazovich D, Anderson K, Folsom A . Relationship of folate, vitamin B-6, vitamin B-12, and methionine intake to incidence of colorectal cancers. Nutr Cancer. 2003; 43(2):152-8. DOI: 10.1207/S15327914NC432_5. View

Andreyev H, Norman A, Cunningham D, Oates J, Dix B, Iacopetta B . Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study. Br J Cancer. 2001; 85(5):692-6. PMC: 2364126. DOI: 10.1054/bjoc.2001.1964. View

Wakai K, Hirose K, Matsuo K, Ito H, Kuriki K, Suzuki T . Dietary risk factors for colon and rectal cancers: a comparative case-control study. J Epidemiol. 2006; 16(3):125-35. PMC: 7603905. DOI: 10.2188/jea.16.125. View

Li J, Zhao L, Wu J, Wu B, Yang H, Zhang H . Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer. J Dig Dis. 2011; 13(1):24-32. DOI: 10.1111/j.1751-2980.2011.00551.x. View

Jenab M, Bueno-de-Mesquita H, Ferrari P, van Duijnhoven F, Norat T, Pischon T . Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ. 2010; 340:b5500. PMC: 2809840. DOI: 10.1136/bmj.b5500. View

Aamodt R, Jonsdottir K, Andersen S, Bondi J, Bukholm G, Bukholm I . Differences in protein expression and gene amplification of cyclins between colon and rectal adenocarcinomas. Gastroenterol Res Pract. 2009; 2009:285830. PMC: 2796221. DOI: 10.1155/2009/285830. View

Servomaa K, Kiuru A, Kosma V, Hirvikoski P, Rytomaa T . p53 and K-ras gene mutations in carcinoma of the rectum among Finnish women. Mol Pathol. 2000; 53(1):24-30. PMC: 1186898. DOI: 10.1136/mp.53.1.24. View

Jarvinen R, Knekt P, Hakulinen T, Rissanen H, Heliovaara M . Dietary fat, cholesterol and colorectal cancer in a prospective study. Br J Cancer. 2001; 85(3):357-61. PMC: 2364063. DOI: 10.1054/bjoc.2001.1906. View

Liang P, Chen T, Giovannucci E . Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2009; 124(10):2406-15. DOI: 10.1002/ijc.24191. View

10.

Erben P, Strobel P, Horisberger K, Popa J, Bohn B, Hanfstein B . KRAS and BRAF mutations and PTEN expression do not predict efficacy of cetuximab-based chemoradiotherapy in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2010; 81(4):1032-8. DOI: 10.1016/j.ijrobp.2010.06.043. View

11.

Bos J, Fearon E, Hamilton S, Verlaan-de Vries M, VAN Boom J, Van Der Eb A . Prevalence of ras gene mutations in human colorectal cancers. Nature. 1987; 327(6120):293-7. DOI: 10.1038/327293a0. View

12.

Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H . Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment Pharmacol Ther. 2009; 30(2):113-25. DOI: 10.1111/j.1365-2036.2009.04022.x. View

13.

Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels A, Maisonneuve P . Smoking and colorectal cancer: a meta-analysis. JAMA. 2008; 300(23):2765-78. DOI: 10.1001/jama.2008.839. View

14.

Larsson S, Wolk A . Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies. Int J Cancer. 2006; 119(11):2657-64. DOI: 10.1002/ijc.22170. View

15.

Davies J, Trembath D, Deal A, Funkhouser W, Calvo B, Finnegan T . Phospho-ERK and AKT status, but not KRAS mutation status, are associated with outcomes in rectal cancer treated with chemoradiotherapy. Radiat Oncol. 2011; 6:114. PMC: 3180690. DOI: 10.1186/1748-717X-6-114. View

16.

Li M, Li J, Zhao A, Gu J . Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology. 2008; 73(1-2):52-7. DOI: 10.1159/000120628. View

17.

Birkenkamp-Demtroder K, Olesen S, Sorensen F, Laurberg S, Laiho P, Aaltonen L . Differential gene expression in colon cancer of the caecum versus the sigmoid and rectosigmoid. Gut. 2005; 54(3):374-84. PMC: 1774427. DOI: 10.1136/gut.2003.036848. View

18.

McDermott F, Hughes E, Pihl E, Milne B, Price A . Comparative results of surgical management of single carcinomas of the colon and rectum: a series of 1939 patients managed by one surgeon. Br J Surg. 1981; 68(12):850-5. DOI: 10.1002/bjs.1800681207. View

19.

Kune G, Watson L . Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene. Nutr Cancer. 2006; 56(1):11-21. DOI: 10.1207/s15327914nc5601_3. View

20.

Zschabitz S, Cheng T, Neuhouser M, Zheng Y, Ray R, Miller J . B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort. Am J Clin Nutr. 2012; 97(2):332-43. PMC: 3545682. DOI: 10.3945/ajcn.112.034736. View